Subfascial excision of a tumor or vascular malformation of the hand or finger measuring 1.5 cm or greater, requiring dissection below the fascial layer into deep soft tissue or muscle.
Verified May 8, 2026 · 6 sources ↓
- Medicare
- $512.04
- Work RVU
- 6.95
- Global, days
- 90
- Region
- Hand
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 6 cited references ↓
- Confirm subfascial depth explicitly — document that dissection extended below the fascial layer, not just into subcutaneous tissue
- Record the exact measured size of the excised specimen (1.5 cm or greater required for 26113 over 26116)
- Specify laterality (left or right hand or finger) and the specific digit or anatomical location within the hand
- Document the nature of the lesion — tumor, ganglion, vascular malformation, or other — and include pathology report correlation
- Describe the surgical approach and technique, including how muscle or fascial planes were managed and whether neurovascular structures were preserved
- Note the indication: pain, functional impairment, suspected malignancy, or growth characteristics driving surgical decision
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 6 cited references ↓
CPT 26113 covers surgical removal of a subfascial (e.g., intramuscular) tumor or vascular malformation from the hand or finger when the lesion measures 1.5 cm or more. The subfascial depth distinguishes this code from its subcutaneous counterpart (26111) — the dissection must go below the fascia, often into muscle planes, to reach the pathology. Smaller deep lesions under 1.5 cm are reported with 26116.
The 90-day global period applies. That means all routine post-op visits, wound care, and stitch removal through day 90 are bundled. Complications requiring a return to the OR for a related issue during that window need modifier 78. An unrelated procedure in the same global period requires modifier 79. Laterality modifiers (LT/RT) are expected on every claim — omitting them is a common reason for rejection.
Tumors that prove to be malignant on pathology may warrant separate coding for radical resection (26117/26118), which carries different documentation and margin-reporting obligations. If pathology results change the clinical picture post-operatively, ensure the operative note and diagnosis codes reflect what was actually found, not just what was suspected preoperatively.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
Work RVU vs. total RVU
The work RVU (6.95) is the surgeon's own effort — the figure physician pay and productivity targets are built on. The total RVU (15.33) adds practice overhead and malpractice, and is what drives the Medicare payment below.
| Work RVU | 6.95 |
| Practice expense RVU | 7.07 |
| Malpractice RVU | 1.31 |
| Total RVU | 15.33 |
| Medicare national rate | $512.04 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $512.04 |
HOPD (APC 5072) Hospital outpatient department | $1,687.37 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $742.04 |
Common denial reasons
The recurring reasons claims for CPT 26113 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Missing laterality modifier (LT or RT) — most payers require it for hand and finger procedures
- Depth not documented: claims denied or down-coded to subcutaneous code 26111 when operative note fails to confirm subfascial dissection
- Lesion size not documented or ambiguous — if the operative or pathology report doesn't confirm ≥1.5 cm, payers will down-code to 26116
- Unbundling conflicts when wound closure or neurolysis codes are billed separately without modifier 59 or XS support
- ICD-10 diagnosis code mismatch — using a benign neoplasm code when pathology returns malignancy, or vice versa, triggers post-payment audits
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What separates 26113 from 26111?
02When do I use 26116 instead of 26113?
03Is a bilateral hand procedure billed with modifier 50 or two line items?
04Does the 90-day global period include physical therapy referrals?
05Can I bill a separate E/M on the day of surgery?
06What if pathology returns malignancy after a 26113 excision?
07Is 26113 subject to NCCI bundling with closure codes?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01mdclarity.comhttps://www.mdclarity.com/cpt-code/26113
- 02aapc.comhttps://www.aapc.com/codes/cpt-codes/26113
- 03emedny.orghttps://www.emedny.org/providermanuals/physician/pdfs/physician%20procedure%20codes%20sect5.pdf
- 04cms.govhttps://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
- 05cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
- 06CMS Physician Fee Schedule 2026
Mira Scribe
Mira's AI scribe captures subfascial depth, exact specimen measurement, digit or hand location, laterality, and the surgeon's description of fascial and muscle plane management directly from dictation. That documentation trio — depth, size, and side — prevents the three most common down-code and denial scenarios for 26113: subcutaneous reclassification to 26111, size-based down-coding to 26116, and laterality rejections.
See how Mira captures CPT 26113 documentation